In Vitro Diagnostics
In Vitro Diagnostics (IVD) has been substantially disrupted by the rise of high technology supply chains in Asia, as well as the proliferation of highly specialized start up biotechnology competitors who have increasingly snatched market share from traditional market leaders.
Accordingly, Virax is positioned in high growth Molecular Diagnosis & Flow Cytometry IVD segments seeing fastest levels of year-on-year development in our sector. Furthermore, our Asia-centric supply chain offers unparalleled cost savings compared to more developed competitors which are more reliant on antiquated and high-priced supply chains.
Virax is committed to providing best in class IVD and immunological testing both in the laboratory and at Point-of-Care.
We are at the front of innovation in point-of-care biomarker testing, bringing new test methodologies and devices that can produce highly accurate, lab-quality results at the bedside or in the home in a matter of minutes.